BBLGBone Biologics Corpvs its industry peers
A metric-by-metric comparison of Bone Biologics Corp against SIC 3842 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBLGThis | $1M#8 | — | 0.4x#3 | 0.0x#2 | 0.0%#6 | 24.4%#1 | -0.3%#1 | -79.2%#4 | — | — | -74.3%#5 | — |
| MYO | $50M#1 | — | 8.5x#7 | 1.2x#4 | 25.7%#1 | -151.6%#7 | -35.2%#3 | -267.6%#7 | — | — | 44.3%#2 | — |
| MLSS | $36M#2 | — | 10.4x#8 | 4.0x#6 | 4.0%#5 | 21.4%#3 | -63.5%#4 | 164.9%#1 | — | — | -32.4%#4 | — |
| BBLGW | $25M#3 | — | 6.2x#6 | 0.0x#3 | 0.0%#6 | 24.4%#1 | -0.3%#1 | -79.2%#4 | — | — | -88.9%#6 | — |
| HSCS | $16M#5 | — | — | 3723.2x#9 | -0.7%#9 | -4.3%#5 | -194787.4%#9 | — | — | — | 2.4%#3 | — |
| FEED | $10M#6 | — | 0.3x#2 | 3.8x#5 | -0.2%#8 | -390.8%#9 | -896.6%#6 | -59.1%#3 | -74.0%#1 | — | -98.9%#7 | — |
| COCHW | $4M#7 | — | 1.2x#4 | 16.6x#7 | 7.1%#4 | -14.2%#6 | -9240.7%#7 | -719.2%#8 | — | — | 151.5%#1 | 45.4%#1 |
| LGMK | $10077#9 | — | 0.0x#1 | 0.0x#1 | 15.4%#2 | 17.1%#4 | -69.1%#5 | -56.6%#2 | -76.3%#2 | 3#2 | — | — |
| CUPR | $23M#4 | — | 5.8x#5 | 590.5x#8 | 9.2%#3 | -216.7%#8 | -9680.1%#8 | -92.4%#6 | -229.7%#3 | 5#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3842). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice